Effect of cyproterone acetate on platelet aggregability, fibrinolytic activity and fibrinolytic capacity in normal men. 1980

M Føgh, and J B Knudsen, and J Gormsen

Nine healthy men were treated with a daily dose of 5 or 10 mg of the anti-androgen cyproterone acetate. Platelet aggregability was increased in 6 of 9 men; fibrinolytic activity decreased in 7 of 7 and the fibrinolytic capacity decreased in 5 of 7 volunteers. We conclude that platelet aggregability, fibrinolytic activity and capacity may be modified by anti-androgen treatment and therefore attention should be paid to the coagulation parameters when cyproterone acetate is used.

UI MeSH Term Description Entries
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Føgh, and J B Knudsen, and J Gormsen
June 1980, Acta endocrinologica,
M Føgh, and J B Knudsen, and J Gormsen
November 1984, The Journal of clinical endocrinology and metabolism,
M Føgh, and J B Knudsen, and J Gormsen
April 1991, Thrombosis research,
M Føgh, and J B Knudsen, and J Gormsen
January 1983, European journal of clinical pharmacology,
M Føgh, and J B Knudsen, and J Gormsen
November 1991, Thrombosis research,
M Føgh, and J B Knudsen, and J Gormsen
October 1979, Contraception,
M Føgh, and J B Knudsen, and J Gormsen
October 1987, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
M Føgh, and J B Knudsen, and J Gormsen
November 1975, Experientia,
M Føgh, and J B Knudsen, and J Gormsen
May 1972, Physiologia Bohemoslovaca,
M Føgh, and J B Knudsen, and J Gormsen
January 1974, International pharmacopsychiatry,
Copied contents to your clipboard!